Medtronic rapped on the knuckles for improper promotion of device
This article was originally published in Clinica
Executive Summary
Medtronic has been accused of improperly promoting its Freestyle Aortic Root Bioprosthesis product, which received FDA approval last November. In a May 12 warning letter from the agency, Medtronic was given 15 working days to correct its promotional material.